+852 3460 3857

體外反搏治療改善新冠病後的呼吸困難、疲勞和「腦霧」症狀

EECP Improves Post-COVID Shortness of Breath, Fatigue, and “Brain Fog”

Source From 資料來源 : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110286/

 

EECP Improves Post-COVID Shortness of Breath, Fatigue, and “Brain Fog”

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible for the coronavirus disease 2019 (COVID-19) pandemic. As patients recover from COVID-19, some continue to report persisting symptoms weeks to months after acute infection. These effects have been referred to as post-acute sequelae of SARS-CoV-2 infection (PASC). We report the case of a 38-year-old woman suffering from PASC symptoms following acute COVID-19 in October 2020. During her acute infection phase, she had a home recovery and reported her predominant symptoms as fatigue, headaches, body pain, and shortness of breath. After most of her symptoms were resolved, she continued to have periodic episodes of fatigue and headaches, along with random shortness of breath while at rest and during activities for months beyond the acute phase of the illness. She also noted the presence of “brain fog,” as if lacking the same clarity that she had prior to her illness. These symptoms persisted for three months before the patient underwent enhanced external counterpulsation (EECP) therapy in one-hour sessions, three times per week. This therapy was chosen based on the mechanism of action of EECP benefiting patients with ischemic cardiovascular diseases. After one week, her “brain fog” had improved, with shortness of breath improving after 1.5 weeks. The patient reported returning to pre-COVID health and fitness after approximately five weeks of EECP treatment. To our knowledge, this is the first case of using EECP for post-COVID shortness of breath, fatigue, and “brain fog.”

 

「增強型體外反搏是治療 COVID-19 急性後遺症的新療法」

SARS-CoV-2是導致2019冠狀病毒病(COVID-19)大流行的病毒。在COVID-19康復期間,一些患者報告在急性感染後的數周至數月持續出現症狀。這些效應被稱為SARS-CoV-2感染的後遺症(PASC)。我們報告了一個38歲女性的病例,她在2020年10月感染COVID-19後出現PASC症狀。在急性感染期間,她在家中康復,主要症狀包括疲勞、頭痛、全身疼痛和呼吸短促。大部分症狀緩解後,她開始出現間歇性的疲勞和頭痛,以及在休息和活動期間出現突發性呼吸困難。她還注意到自己出現了「 腦霧 」的症狀,感覺不再像患病之前那樣清晰。這些症狀持續了三個月,然後患者接受了每週三次、每次一小時的增強型體外反搏治療(EECP)。選擇這種治療是基於EECP的作用機制對缺血性心血管疾病患者有益。一周後,她的「 腦霧 」症狀有所改善,呼吸困難在1.5周後改善。患者報告在接受約五週的EECP治療後恢復到COVID-19之前的健康和體能狀態。據我們所知,這是首個使用EECP治療COVID-19後呼吸困難、疲勞和「 腦霧 」的病例。

WhatsApp chat